Harvard Bioscience (HBIO) Stock Chart & Stock Price History → Don’t Miss Out on the AI Gold Rush That’s Just Getting Started (From Banyan Hill Publishing) (Ad) Free HBIO Stock Alerts $3.70 0.00 (0.00%) (As of 04/22/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Harvard Bioscience Stock Price Performance5 Day Performance-9.54%1 Month Performance-11.27%3 Month Performance-17.96%6 Month Performance-13.55%Year-To-Date Performance-30.84%1 Year Performance-24.34% Receive HBIO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Harvard Bioscience and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Banyan Hill PublishingDon’t Miss Out on the AI Gold Rush That’s Just Getting Started“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him HBIO Stock Chart for Tuesday, April, 23, 2024 HBIO Chart by TradingView Harvard Bioscience Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/19/2024$3.97$3.70-6.80%$4.02$3.6987,253 shs$160.58 million04/18/2024$4.09$3.97-2.93%$4.31$3.87126,600 shs$172.30 million04/17/2024$4.18$4.09-2.15%$4.37$4.0986,016 shs$177.51 million04/16/2024$4.44$4.18-5.86%$4.42$4.1566,030 shs$181.41 million04/15/2024$4.24$4.44+4.72%$4.45$4.15192,772 shs$192.70 million04/12/2024$4.35$4.24-2.42%$4.40$4.1992,929 shs$184.02 million Get the Latest News and Ratings for HBIO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Harvard Bioscience and its competitors with MarketBeat's FREE daily newsletter. 04/11/2024$4.26$4.35+2.00%$4.37$4.1255,972 shs$188.57 million04/10/2024$4.63$4.26-7.99%$4.62$4.16115,526 shs$184.88 million04/09/2024$4.31$4.63+7.42%$4.65$4.3398,402 shs$200.94 million04/08/2024$4.52$4.31-4.65%$4.66$4.24185,397 shs$187.05 million04/05/2024$4.47$4.52+1.12%$4.58$4.3834,478 shs$196.16 million04/04/2024$4.20$4.47+6.43%$4.70$4.30150,177 shs$194.00 million04/03/2024$4.17$4.20+0.72%$4.26$4.1292,084 shs$182.28 million04/02/2024$4.26$4.17-2.11%$4.24$4.0450,628 shs$180.98 million04/01/2024$4.24$4.26+0.47%$4.29$4.2063,365 shs$184.88 million03/29/2024$4.24$4.24$4.31$4.1793,670 shs$184.02 million03/28/2024$4.20$4.24+0.95%$4.31$4.1793,670 shs$184.02 million03/27/2024$4.02$4.20+4.48%$4.20$3.9781,812 shs$182.28 million03/26/2024$4.13$4.02-2.66%$4.20$3.9287,104 shs$174.47 million03/25/2024$4.17$4.13-0.96%$4.23$4.1038,562 shs$179.24 million03/22/2024$4.36$4.17-4.36%$4.37$4.0693,246 shs$180.98 million03/21/2024$4.40$4.36-0.91%$4.42$4.2653,829 shs$189.22 million03/20/2024$4.40$4.40$4.41$4.2368,685 shs$190.96 million03/19/2024$4.15$4.40+6.02%$4.44$4.1551,840 shs$190.96 million03/18/2024$4.05$4.15+2.47%$4.30$3.84415,147 shs$180.11 million03/15/2024$4.29$4.05-5.59%$4.33$4.04337,205 shs$175.77 million03/14/2024$4.39$4.29-2.28%$4.44$4.2673,945 shs$186.19 million03/13/2024$4.27$4.39+2.81%$4.40$4.2069,254 shs$190.53 million03/12/2024$4.36$4.27-2.06%$4.44$4.2454,335 shs$185.32 million03/11/2024$4.42$4.36-1.36%$4.50$4.1690,730 shs$186.12 million03/08/2024$4.51$4.42-2.00%$4.59$4.3651,006 shs$188.69 million03/07/2024$4.11$4.51+9.73%$4.61$4.0682,389 shs$192.53 million03/06/2024$4.19$4.11-1.91%$4.41$4.0556,366 shs$175.45 million03/05/2024$4.37$4.19-4.12%$4.47$4.1538,835 shs$178.87 million03/04/2024$4.35$4.37+0.46%$4.49$4.3029,681 shs$186.56 million03/01/2024$4.33$4.35+0.46%$4.38$4.2841,465 shs$185.69 million02/29/2024$4.38$4.33-1.14%$4.48$4.2457,267 shs$184.85 million02/28/2024$4.42$4.38-0.90%$4.47$4.3728,810 shs$186.98 million02/27/2024$4.37$4.42+1.14%$4.50$4.3567,052 shs$188.69 million02/26/2024$4.41$4.37-0.91%$4.49$4.3233,754 shs$186.56 millionDon’t Miss Out on the AI Gold Rush That’s Just Getting Started (Ad)“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him02/23/2024$4.40$4.41+0.23%$4.46$4.3725,639 shs$188.26 million02/22/2024$4.44$4.40-0.90%$4.49$4.3163,387 shs$187.84 million02/21/2024$4.33$4.44+2.54%$4.49$4.2048,279 shs$189.54 million02/20/2024$4.52$4.33-4.20%$4.52$4.2483,622 shs$184.85 million02/19/2024$4.52$4.52$4.88$4.5076,900 shs$192.96 million02/16/2024$4.86$4.52-7.00%$4.88$4.5076,973 shs$192.96 million02/15/2024$4.69$4.86+3.62%$4.91$4.5962,302 shs$207.47 million02/14/2024$4.36$4.69+7.57%$4.78$4.38151,372 shs$200.22 million02/13/2024$4.81$4.36-9.36%$4.93$4.22107,972 shs$186.13 million02/12/2024$4.73$4.81+1.69%$4.91$4.7182,882 shs$205.34 million02/09/2024$4.67$4.73+1.28%$4.83$4.6744,067 shs$201.92 million02/08/2024$4.65$4.67+0.43%$4.70$4.5937,012 shs$199.36 million02/07/2024$4.68$4.65-0.64%$4.77$4.6240,383 shs$198.51 million02/06/2024$4.50$4.68+4.00%$4.77$4.44111,329 shs$199.78 million02/05/2024$4.52$4.50-0.44%$4.59$4.36247,203 shs$192.11 million02/02/2024$4.52$4.52$4.63$4.4671,622 shs$192.96 million02/01/2024$4.40$4.52+2.73%$4.62$4.41160,651 shs$192.96 million01/31/2024$4.57$4.40-3.72%$4.60$4.3876,537 shs$187.84 million01/30/2024$4.64$4.57-1.51%$4.63$4.4637,691 shs$195.09 million01/29/2024$4.56$4.64+1.75%$4.70$4.5739,676 shs$198.08 million01/26/2024$4.61$4.56-1.08%$4.75$4.4845,638 shs$194.67 million01/25/2024$4.49$4.61+2.67%$4.64$4.5065,693 shs$196.80 million01/24/2024$4.61$4.49-2.60%$4.76$4.4958,348 shs$191.68 million01/23/2024$4.51$4.61+2.22%$4.62$4.5169,563 shs$196.80 million01/22/2024$4.30$4.51+4.88%$4.51$4.2763,017 shs$192.52 million Related Companies: OPRX Stock Chart APPS Stock Chart QUIK Stock Chart ASUR Stock Chart CANG Stock Chart III Stock Chart OOMA Stock Chart KLTR Stock Chart TRVG Stock Chart INOD Stock Chart Receive HBIO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Harvard Bioscience and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:HBIO) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithHealthcare Takes A Big Step Forward With The Help Of AIThe Bull Reporttop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill Publishing[Shocking] Elon Musk’s Plan To End BanksCrypto 101 MediaUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Harvard Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.